Literature DB >> 31294568

Superior Penetration and Cytotoxicity of HPMA Copolymer Conjugates of Pirarubicin in Tumor Cell Spheroid.

Hideaki Nakamura1, Eva Koziolová2, Petr Chytil2, Tomáš Etrych2, Mamoru Haratake1, Hiroshi Maeda3,4.   

Abstract

N-(2-Hydroxypropyl)methacrylamide copolymer conjugates of pirarubicin (THP), P-THP, accumulates selectively in solid tumor tissue by the enhanced permeability and retention (EPR) effect. Despite of high accumulation in solid tumors, some macromolecular antitumor agents show poor therapeutic outcome because of poor tissue diffusion into the tumor as well as obstructed tumor blood flow. Here, we confirmed that cellular uptake of P-THP was 25 times less than that of free THP at 1-4 h incubation time in vitro. The passage of P-THP through the confluent tight-monolayer cells junction was 12 times higher than free THP, and P-THP penetrated deeper into the tumor cell spheroid (1.3-1.7-fold) than free THP in 4 h. In addition, P-THP showed cytotoxicity comparable to that of free THP to tumor-cells in spheroid form, despite of 7 times lower cytotoxicity of P-THP to the monolayer cells to that of free THP in vitro. These results indicate that P-THP administration can exhibit deeper diffusion into the tumor cell spheroid than free THP. As a consequence, P-THP exhibits more efficient antitumor activity than free THP in vivo, which is also supported by better pharmacokinetics and tumor accumulation of P-THP than free THP.

Entities:  

Keywords:  HPMA polymer; drug delivery; penetration; pirarubicin (THP); tumor spheroid cell

Mesh:

Substances:

Year:  2019        PMID: 31294568     DOI: 10.1021/acs.molpharmaceut.9b00248

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  3 in total

1.  LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo.

Authors:  Chen He; Zhiyuan Zhang; Yinan Ding; Kangli Xue; Xihui Wang; Rui Yang; Yanli An; Dongfang Liu; Chunmei Hu; Qiusha Tang
Journal:  J Nanobiotechnology       Date:  2021-01-22       Impact factor: 10.435

Review 2.  The 35th Anniversary of the Discovery of EPR Effect: A New Wave of Nanomedicines for Tumor-Targeted Drug Delivery-Personal Remarks and Future Prospects.

Authors:  Hiroshi Maeda
Journal:  J Pers Med       Date:  2021-03-22

3.  Structure-to-Efficacy Relationship of HPMA-Based Nanomedicines: The Tumor Spheroid Penetration Study.

Authors:  Júlia Kudláčová; Lenka Kotrchová; Libor Kostka; Eva Randárová; Marcela Filipová; Olga Janoušková; Jun Fang; Tomáš Etrych
Journal:  Pharmaceutics       Date:  2020-12-20       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.